PDB Short entry for 1IAU HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAR-01 1IAU TITLE HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: GRANZYME B; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.79; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ACETYL-ISOLEUCYL-GLUTAMYL-PROLYL-ASPARTYL-ALDEHYDE PEPTIDE COMPND 8 INHIBITOR; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: ACE-ILE-GLU-PRO-ASP-CHO; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ROTONDA,M.GARCIA-CALVO,H.G.BULL,W.M.GEISSLER,B.M.MCKEEVER, AUTHOR 2 C.A.WILLOUGHBY,N.A.THORNBERRY,J.W.BECKER REVDAT 7 15-NOV-23 1IAU 1 REMARK REVDAT 6 09-AUG-23 1IAU 1 HETSYN REVDAT 5 29-JUL-20 1IAU 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 04-APR-12 1IAU 1 HET HETATM HETNAM LINK REVDAT 4 2 1 REMARK SEQRES REVDAT 3 13-JUL-11 1IAU 1 VERSN REVDAT 2 24-FEB-09 1IAU 1 VERSN REVDAT 1 02-MAY-01 1IAU 0 JRNL AUTH J.ROTONDA,M.GARCIA-CALVO,H.G.BULL,W.M.GEISSLER,B.M.MCKEEVER, JRNL AUTH 2 C.A.WILLOUGHBY,N.A.THORNBERRY,J.W.BECKER JRNL TITL THE THREE-DIMENSIONAL STRUCTURE OF HUMAN GRANZYME B COMPARED JRNL TITL 2 TO CASPASE-3, KEY MEDIATORS OF CELL DEATH WITH CLEAVAGE JRNL TITL 3 SPECIFICITY FOR ASPARTIC ACID IN P1. JRNL REF CHEM.BIOL. V. 8 357 2001 JRNL REFN ISSN 1074-5521 JRNL PMID 11325591 JRNL DOI 10.1016/S1074-5521(01)00018-7 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 19942 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE-R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2027 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2340 REMARK 3 BIN R VALUE (WORKING SET) : 0.3300 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1815 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 58 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.025 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUE 245 IS MISSING IN THE ELECTRON REMARK 3 DENSITY. SHELX WAS ALSO USED FOR THE FINAL REFINEMENT TO MODEL REMARK 3 DISORDER. REMARK 4 REMARK 4 1IAU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-01. REMARK 100 THE DEPOSITION ID IS D_1000013107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : NON-FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19956 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 8.200 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.67 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: CATHEPSIN G (PDB ENTRY 1CGH) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5 UL DROPS OF PROTEIN-INHIBITOR REMARK 280 SOLUTION (12.2 MG/ML IN 20 MM TRIS-HCL PH 8.0, 200 MM NACL) WERE REMARK 280 MIXED WITH AN EQUAL VOLUME OF PRECIPITANT SOLUTION (25% PEG REMARK 280 MONOMETHYLETHER-550 (V/V), 0.10 M MES PH 6.5, 10 MM ZNSO(4), 12 REMARK 280 MM ZNCL(2)) AND INCUBATED AT ROOM TEMPERATURE OVER A RESERVOIR REMARK 280 OF 24% W/V PEG-3350, 12.8% V/V PEG MME-550, 50 MM MES PH 6.5, 5 REMARK 280 MM ZNSO(4), AND 6 MM ZNCL(2). REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.43650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.13050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.54050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.13050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.43650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.54050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -106.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THERE IS A COVALENT BOND BETWEEN ATOM OG OF SER195A AND ATOM C OF REMARK 400 ASJ405B, FORMING A HEMIACETAL REMARK 400 REMARK 400 THE N-ACETYL-L-ISOLEUCYL-L-ALPHA-GLUTAMYL-N-[(1S)-2-CARBOXY-1- REMARK 400 FORMYLETHYL]-L-PROLINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-ISOLEUCYL-L-ALPHA-GLUTAMYL-N-[(1S)-2-CARBOXY-1- REMARK 400 FORMYLETHYL]-L-PROLINAMIDE REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 245 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 37 -123.38 -75.63 REMARK 500 THR A 54 -164.21 -162.43 REMARK 500 HIS A 71 -65.49 -126.61 REMARK 500 PHE A 99 17.15 58.81 REMARK 500 PRO A 145A 1.62 -59.35 REMARK 500 LEU A 146 -5.65 -152.79 REMARK 500 HIS A 151 176.41 -55.87 REMARK 500 HIS A 173 -21.79 84.70 REMARK 500 LYS A 203 16.73 59.10 REMARK 500 SER A 214 -68.92 -125.64 REMARK 500 ASN A 218 5.68 -67.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 504 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 20 NE2 REMARK 620 2 GLU A 157 OE2 105.2 REMARK 620 3 HOH A 653 O 104.9 97.4 REMARK 620 4 HOH A 655 O 137.3 91.2 111.7 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 GLU A 77 OE2 122.9 REMARK 620 3 HOH A 605 O 93.9 106.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 151 NE2 REMARK 620 2 HIS A 153 NE2 118.9 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 503 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 169 OE2 REMARK 620 2 GLU A 169 OE1 57.1 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 505 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 184 OD1 REMARK 620 2 HOH A 649 O 84.9 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FQ3 RELATED DB: PDB REMARK 900 HUMAN GRANZYME B (UNINHIBITED) REMARK 900 RELATED ID: 1FI8 RELATED DB: PDB REMARK 900 RAT GRANZYME B WITH ECOTIN FRAGMENT REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE RESIDUE NUMBERS FOR CHAIN A ARE NOT SEQUENTIAL. THE NUMBERING REMARK 999 SCHEME IS BASED ON THE FAMILY OF SERINE PROTEASES AND IS BASED ON REMARK 999 THE ZYMOGEN CHYMOTRYPSINOGEN DBREF 1IAU A 16 245 UNP P10144 GRAB_HUMAN 21 247 DBREF 1IAU B 401 405 PDB 1IAU 1IAU 401 405 SEQADV 1IAU ARG A 48 UNP P10144 GLN 55 VARIANT SEQRES 1 A 227 ILE ILE GLY GLY HIS GLU ALA LYS PRO HIS SER ARG PRO SEQRES 2 A 227 TYR MET ALA TYR LEU MET ILE TRP ASP GLN LYS SER LEU SEQRES 3 A 227 LYS ARG CYS GLY GLY PHE LEU ILE ARG ASP ASP PHE VAL SEQRES 4 A 227 LEU THR ALA ALA HIS CYS TRP GLY SER SER ILE ASN VAL SEQRES 5 A 227 THR LEU GLY ALA HIS ASN ILE LYS GLU GLN GLU PRO THR SEQRES 6 A 227 GLN GLN PHE ILE PRO VAL LYS ARG PRO ILE PRO HIS PRO SEQRES 7 A 227 ALA TYR ASN PRO LYS ASN PHE SER ASN ASP ILE MET LEU SEQRES 8 A 227 LEU GLN LEU GLU ARG LYS ALA LYS ARG THR ARG ALA VAL SEQRES 9 A 227 GLN PRO LEU ARG LEU PRO SER ASN LYS ALA GLN VAL LYS SEQRES 10 A 227 PRO GLY GLN THR CYS SER VAL ALA GLY TRP GLY GLN THR SEQRES 11 A 227 ALA PRO LEU GLY LYS HIS SER HIS THR LEU GLN GLU VAL SEQRES 12 A 227 LYS MET THR VAL GLN GLU ASP ARG LYS CYS GLU SER ASP SEQRES 13 A 227 LEU ARG HIS TYR TYR ASP SER THR ILE GLU LEU CYS VAL SEQRES 14 A 227 GLY ASP PRO GLU ILE LYS LYS THR SER PHE LYS GLY ASP SEQRES 15 A 227 SER GLY GLY PRO LEU VAL CYS ASN LYS VAL ALA GLN GLY SEQRES 16 A 227 ILE VAL SER TYR GLY ARG ASN ASN GLY MET PRO PRO ARG SEQRES 17 A 227 ALA CYS THR LYS VAL SER SER PHE VAL HIS TRP ILE LYS SEQRES 18 A 227 LYS THR MET LYS ARG TYR SEQRES 1 B 5 ACE ILE GLU PRO ASJ MODRES 1IAU ASN A 65 ASN GLYCOSYLATION SITE MODRES 1IAU ASN A 98 ASN GLYCOSYLATION SITE HET ACE B 401 3 HET ASJ B 405 16 HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET NAG C 4 14 HET BMA C 5 11 HET FUC C 6 10 HET NAG A 301 14 HET ZN A 501 1 HET ZN A 502 1 HET ZN A 503 1 HET ZN A 504 1 HET ZN A 505 1 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 ACE C2 H4 O FORMUL 2 ASJ C4 H9 N O3 FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 MAN C6 H12 O6 FORMUL 3 BMA C6 H12 O6 FORMUL 3 FUC C6 H12 O5 FORMUL 5 ZN 5(ZN 2+) FORMUL 10 HOH *58(H2 O) HELIX 1 1 ALA A 55 TRP A 59 5 5 HELIX 2 2 GLU A 164 LEU A 172 1 9 HELIX 3 3 PHE A 234 ARG A 244 1 11 SHEET 1 A 7 HIS A 20 GLU A 21 0 SHEET 2 A 7 GLN A 156 THR A 161 -1 O GLU A 157 N HIS A 20 SHEET 3 A 7 THR A 135 GLY A 140 -1 N CYS A 136 O MET A 160 SHEET 4 A 7 PRO A 198 CYS A 201 -1 O PRO A 198 N ALA A 139 SHEET 5 A 7 VAL A 204 TYR A 215 -1 O VAL A 204 N CYS A 201 SHEET 6 A 7 ARG A 226 LYS A 230 -1 N ALA A 227 O TYR A 215 SHEET 7 A 7 GLU A 180 VAL A 183 -1 O LEU A 181 N CYS A 228 SHEET 1 B 7 MET A 30 TRP A 36 0 SHEET 2 B 7 LEU A 39 ARG A 48 -1 N LYS A 40 O ILE A 35 SHEET 3 B 7 PHE A 51 THR A 54 -1 N PHE A 51 O ARG A 48 SHEET 4 B 7 MET A 104 LEU A 108 -1 N MET A 104 O THR A 54 SHEET 5 B 7 GLN A 81 PRO A 90 -1 N LYS A 86 O GLN A 107 SHEET 6 B 7 SER A 63 LEU A 68 -1 O ILE A 64 N VAL A 85 SHEET 7 B 7 MET A 30 TRP A 36 -1 N TYR A 32 O THR A 67 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.05 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.02 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 LINK ND2 ASN A 65 C1 NAG A 301 1555 1555 1.44 LINK ND2 ASN A 98 C1 NAG C 1 1555 1555 1.47 LINK OG ASER A 195 C AASJ B 405 1555 1555 1.47 LINK OG BSER A 195 C BASJ B 405 1555 1555 1.48 LINK C ACE B 401 N ILE B 402 1555 1555 1.33 LINK C PRO B 404 N AASJ B 405 1555 1555 1.33 LINK C PRO B 404 N BASJ B 405 1555 1555 1.33 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O6 NAG C 1 C1 FUC C 6 1555 1555 1.39 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.39 LINK O4 MAN C 3 C1 NAG C 4 1555 1555 1.40 LINK O6 MAN C 3 C1 BMA C 5 1555 1555 1.40 LINK NE2 HIS A 20 ZN ZN A 504 1555 1555 1.78 LINK NE2 HIS A 25 ZN ZN A 502 1555 1555 2.05 LINK OE2 GLU A 77 ZN ZN A 502 1555 1555 2.12 LINK NE2 HIS A 151 ZN ZN A 501 1555 1555 2.39 LINK NE2 HIS A 153 ZN ZN A 501 1555 1555 1.89 LINK OE2 GLU A 157 ZN ZN A 504 1555 1555 2.22 LINK OE2 GLU A 169 ZN ZN A 503 1555 1555 1.85 LINK OE1 GLU A 169 ZN ZN A 503 1555 1555 2.56 LINK OD1 ASP A 184 ZN ZN A 505 1555 1555 2.33 LINK ZN ZN A 502 O HOH A 605 1555 1555 2.07 LINK ZN ZN A 504 O HOH A 653 1555 1555 2.55 LINK ZN ZN A 504 O HOH A 655 1555 1555 2.09 LINK ZN ZN A 505 O HOH A 649 1555 1555 1.70 CISPEP 1 PRO A 224 PRO A 225 0 2.81 CRYST1 48.873 75.081 80.261 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020461 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013319 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012459 0.00000